Acral Lentiginous Melanoma
specificA form of melanoma occurring most often on the plantar, palmar, subungual, and periungual skin. It presents as a pigmented macular lesion with irregular borders. Morphologically, it consists of atypical spindled and dendritic melanocytes. The epidermis is often hyperplastic and there is pagetoid infiltration of the epidermis by anaplastic cells.
32
Centers
34
Active Trials
—
Cancer Funding
Top Centers for Acral Lentiginous Melanoma(32)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 68.4 |
| 2 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 68.4 |
| 3 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 68.4 |
| 4 | NCI Clinical Active Research Program | 68.4 |
| 5 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 68.4 |
| 6 | University of Illinois Cancer CenterChicago, IL Active Research Program | 68.4 |
| 7 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 68.4 |
| 8 | Cancer Center at IllinoisUrbana, IL Active Research Program | 68.4 |
| 9 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 50.2 |
| 10 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 50.2 |
| 11 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 50.2 |
| 12 | NCI Comprehensive Active Research Program | 50.2 |
| 13 | NCI Comprehensive Active Research Program | 50.2 |
| 14 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 50.2 |
| 15 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 50.2 |
| 16 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive Active Research Program | 50.2 |
| 17 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 50.2 |
| 18 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 50.2 |
| 19 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 50.2 |
| 20 | Atrium Health Wake Forest Baptist Comprehensive Cancer CenterWinston-Salem, NC NCI Comprehensive Active Research Program | 50.2 |
| 21 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 50.2 |
| 22 | Boston University Cancer CenterBoston, MA Active Research Program | 50.2 |
| 23 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 50.2 |
| 24 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 50.2 |
| 25 | Active Research Program | 50.2 |
| 26 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 50.2 |
| 27 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 33.3 |
| 28 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive | 33.3 |
| 29 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive | 33.3 |
| 30 | Stephenson Cancer CenterOklahoma City, OK NCI Clinical | 33.3 |
| 31 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL | 33.3 |
| 32 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ | 33.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →